Zentiva’s Ownership Change: A New Era for Romania’s Generics Zentiva, the largest producer of generic medications in Romania, is set for a significant ownership change as it prepares to be acquired by the American private equity firm GTCR. This transaction, valued at a staggering 4.1 billion euros, marks a pivotal moment in the Romanian pharmaceutical…